Saturday, August 9, 2025
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Biology

Improving life quality in chronic limb-threatening ischemia through revascularization

May 15, 2024
in Biology
Reading Time: 3 mins read
0
66
SHARES
601
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT
ADVERTISEMENT

A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia. This study stands as a pivotal exploration into the comparative effectiveness of surgical bypass (Bypass) versus endovascular intervention (Endo) across multiple patient cohorts. Ochsner Health chairman of cardiovascular disease and director of the John Ochsner Heart & Vascular Institute, Dr. Christopher White, was a contributing author on the publication. 

A recent publication in the American Heart Association Circulation highlights a comprehensive investigation to assess the impact of revascularization strategies on the health-related quality of life (HRQoL) of patients suffering from chronic limb-threatening ischemia. This study stands as a pivotal exploration into the comparative effectiveness of surgical bypass (Bypass) versus endovascular intervention (Endo) across multiple patient cohorts. Ochsner Health chairman of cardiovascular disease and director of the John Ochsner Heart & Vascular Institute, Dr. Christopher White, was a contributing author on the publication. 

The study categorized patients into two cohorts based on the availability of a single-segment great saphenous vein, which is critical for surgical bypass procedures. HRQoL was assessed using a suite of tools including Vascular Quality-of-Life (VascuQoL), European Quality-of-Life-5D (EQ-5D), the Short Form-12 Physical and Mental Component Summaries (SF-12 PCS & MCS), Utility Index Score (SF-6D R2), and various numeric rating scales of pain. The analysis employed mixed-model linear regression to compare HRQoL outcomes both within and between treatment groups over the duration of the trial.   

The analysis encompassed 1193 patients in cohort 1 and 335 patients in cohort 2, with mean follow-up durations of 2.9 and 2.0 years, respectively. Findings revealed that patients in both cohorts experienced significant improvements in HRQoL from baseline to follow-up across all measures assessed. Notably, in cohort 1, several HRQoL measures favored the Endo group, including VascuQoL, SF-12 MCS, SF-6D R2, and various pain scales. However, these differences, while statistically significant, did not surpass the threshold for clinical meaningfulness. Conversely, no significant differences were observed between the Bypass and Endo groups in cohort 2 on any HRQoL measure.   

Dr. Christopher White, a contributing author to the study, stated, “In patients with chronic limb-threatening ischemia deemed eligible for either Bypass or Endo, revascularization resulted in significant and clinically meaningful improvements in HRQoL. The results of the BEST-CLI trial underscore the profound impact revascularization can have on patients’ lives, not just in terms of physical health but also in their overall quality of life. These findings highlight the importance of patient-centered care approaches in vascular surgery and the need for continued innovation in treatment strategies.”   

The study unequivocally demonstrates that revascularization—whether through Bypass or Endo—significantly enhances the HRQoL for patients with chronic limb-threatening ischemia. For patients with an available single-segment great saphenous vein, Endo showed slight statistical superiority in some HRQoL measures over Bypass, albeit these differences were not clinically substantial. This finding underscores the effectiveness of revascularization in improving the quality of life for patients facing this severe condition, regardless of the specific intervention applied.   

 

### 

 

About Ochsner Health  

Ochsner Health is the leading not-for-profit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 12 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians. To learn more about how Ochsner empowers people to get well and stay well, visit https://www.ochsner.org/.  



Journal

Circulation

DOI

10.1161/circulationaha.123.065277

Article Title

Quality of Life in Patients With Chronic Limb-Threatening Ischemia Treated With Revascularization

Article Publication Date

16-Apr-2024

Share26Tweet17
Previous Post

Two genes of the germline are essential for the development of brain tumours in Drosophila

Next Post

The microbiome clinical revolution: Key messages and tonality of the upcoming global targeting microbiota conference

Related Posts

Biology

Scientists Discover Novel Mechanism Behind Cellular Tolerance to Anticancer Drugs

August 9, 2025
blank
Biology

Onchocerca ochengi Infection Impacts Gerbil Behavior, Physiology

August 9, 2025
blank
Biology

Decoding Finch Louse Fly Morphotypes: Taxonomy Insight

August 9, 2025
blank
Biology

How Immune Cells Flip the Switch to Launch an Attack

August 9, 2025
blank
Biology

Molecular Study and Risks of Hepatozoon Canis in Haryana Dogs

August 8, 2025
blank
Biology

Unraveling the Nuclear Phosphoinositide-p53 Signalosome: A Key Regulator of Cell Motility

August 8, 2025
Next Post
Targeting Microbiota 2024: The Microbiome Clinical Revolution - October 14-15, Malta

The microbiome clinical revolution: Key messages and tonality of the upcoming global targeting microbiota conference

  • Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27531 shares
    Share 11009 Tweet 6881
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    943 shares
    Share 377 Tweet 236
  • Bee body mass, pathogens and local climate influence heat tolerance

    641 shares
    Share 256 Tweet 160
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    507 shares
    Share 203 Tweet 127
  • Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn

    310 shares
    Share 124 Tweet 78
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • Revolutionizing Fetal Congenital Heart Disease: MRI’s Impact
  • Distinct Coral Reef Regions Identified in Red Sea
  • Scientists Discover Novel Mechanism Behind Cellular Tolerance to Anticancer Drugs
  • Enhancing Pediatric Abdominal MRI Quality with Deep Learning

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,860 other subscribers

© 2025 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2025 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading